Trial intelligence / Profile preview

Preoperative calcitriol to prevent post-thyroidectomy hypocalcaemia

DRKS00005615Phase 4Completed

Sponsor
Sana Klinikum Offenbach
Start
Jan 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of calcitriol in diffuse non-toxic goiter and benign thyroid disease (2 arms), sponsored by Sana Klinikum Offenbach. Primary endpoint: Postoperative hypocalcaemia incidence. Started Jan 2014; status: completed.

02

Drugs

calcitriol
03

Conditions

diffuse non-toxic goiterbenign thyroid disease

Beyond the preview

Go deeper on DRKS00005615.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00005615.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call